A fifty-five-year-old senior partner at a Lagos law firm sits in the consulting room on a Thursday afternoon, having been booked in by his wife under the description of "exhaustion that is not responding to his usual rest." He is articulate, well-presented, slightly heavier than he was when his last full physical was performed three years ago, and apologetic — twice in the first ten minutes — for taking up the time. He has had a successful career. He has, on the visible measures, no specific reason to be unhappy. He describes his presenting complaint as fatigue. He uses the word tired eleven times in the consultation. He does not use the word sad, the word low, the word hopeless, or any of the words the diagnostic manual was written around, at any point in the appointment. His wife, who has been waiting outside, is invited in for the closing five minutes and says, without prompting, that for two and a half years she has not recognised the man she has been married to for twenty-eight.
The diagnosis, in the clinical reading of the case, is not subtle. The patient meets every criterion of a moderate-to-severe major depressive episode, has met them for somewhere between two and three years, has been seen during this window by his GP, by an internist, by a cardiologist, and by a sleep clinician, and has been told by each of them, in one form of words or another, that what he needs is to rest. He has not been told once, by any of them, that he is depressed. He has not, in his own internal narrative of his case, considered the word as a possibility about himself.
This is the most clinically consequential under-diagnosis in the medicine of the Nigerian professional class. It is not a matter of psychiatric exoticism. It is not a matter of stigma in the form it is usually framed. It is the slow, systematic mis-translation of a measurable, treatable clinical condition into a vocabulary of stress, tiredness, Lagos, and workload that allows the patient, his family, his colleagues, and his physicians to avoid the diagnosis the panel and the examination would, with very little effort, make.
What depression looks like in the Nigerian professional
The most important clinical fact about depression in the Nigerian professional demographic is that it does not look like the textbook presentation the practitioner was taught to expect. The textbook patient describes sadness, loss of pleasure, feelings of worthlessness, suicidal ideation, and inability to function. The Nigerian executive in his fifties presents with none of these — at least, with none of these in the words the clinician is listening for. He presents with somatic and behavioural surrogates, each of which is, in isolation, attributable to something else, and each of which the patient has spent years explaining to himself in terms that did not include the underlying diagnosis.
The somatic presentation is the dominant one. The patient is tired, in a way that does not respond to sleep, that is worst on Sunday evenings, that is heavier on the body than the workload should explain, and that has been getting steadily worse across a slow eighteen-to-thirty-month gradient. He has unexplained physical symptoms — a headache pattern that is new for him, a low-back pain that does not have a clear musculoskeletal explanation, an intermittent epigastric discomfort that has been investigated three times and resolved to nothing. He has gained or lost weight in a way that does not match any specific dietary change. His sleep is broken — early-morning awakening at three or four, lying awake until five, falling back into a heavy sleep at six that the alarm interrupts an hour later. The fatigue, the somatic complaints, and the early-morning awakening together are, on the clinical literature, one of the cleanest diagnostic patterns in psychiatry. They are, in Nigerian primary care, almost never read as depression.
The behavioural presentation is the second, and the one the family notices long before the clinician does. The patient has stopped enjoying things he used to enjoy. Not abruptly. He still attends the golf on Saturday morning, still goes to the family events, still appears at the partners' dinner — but he is no longer present during any of these, and the people who know him best can feel the difference even if they cannot name it. He has become irritable in a way he was not before. His patience with his children, his staff, and his driver is shorter. He drinks somewhat more than he did. He has lost some interest in sex, but has not raised it because it has accumulated slowly enough that no single conversation has been the right moment. He is, in the description his wife gives in the consultation room, not himself. Almost every spouse in the demographic uses some version of those exact words.
The cognitive presentation is the third. The patient is, by his own subjective assessment and by any objective one if it is performed, slower than he was. He forgets things he used not to forget. His ability to read a complex matter for the first time and form an opinion in a single sitting is impaired. He attributes this to ageing, to the workload, to the lack of sleep. It is, when the depression is treated, almost entirely reversible. It is not ageing.
The clinically critical absence — the absence that allows almost all of this to slip past the clinician — is that the patient does not describe himself as sad. He is not the textbook depressed patient. He is the man who has built a successful life, who has no specific present grievance against the world, and who is, somatically and behaviourally, in the middle of a depressive episode he does not have a vocabulary to name from the inside.
Why the Nigerian professional cohort is particularly at risk
The under-recognition of depression in this demographic is not random. It is structurally produced by three specific features of the cohort, and naming them is the first step toward catching the diagnosis earlier.
The first is the self-image of the professional. The Lagos senior partner, the Abuja oil-and-gas principal, the Port Harcourt clinic owner, and the Victoria Island banker have constructed an identity around competence, control, provision, and the ability to absorb load that the people around them cannot. Depression, in their internal categorisation, is something that happens to people who cannot cope. They are, by definition, the people who cope. The diagnostic possibility is therefore foreclosed before the consultation begins. The patient will not bring it up. He will, frequently, deflect it actively if it is gently proposed.
The second is the masking effect of the workload. The Nigerian professional life is genuinely demanding. The hours are long. The stakes are high. The recovery windows are limited. The depressive symptoms — the fatigue, the loss of pleasure, the irritability, the cognitive slowing — are, in real time, attributable to the workload, and the workload provides a coherent explanation that the patient and his family find more comfortable than the psychiatric one. The explanation is partially correct. The workload is, in some patients, the precipitant. But the explanation is also a screen, and once the depressive episode is established, the workload does not lift it. Removing the workload at the height of an established episode improves matters incompletely and frequently not at all.
The third is the clinician's vocabulary. The Nigerian primary-care physician is, in the main, reluctant to use the word depression about a patient who has not used it about himself. The reluctance is partly a residual stigma, partly a concern about offending a patient who is socially senior to the clinician, partly a learned habit of medicalising the somatic complaint that has been presented rather than re-framing the underlying condition. The patient is therefore told that he is stressed, that his cortisol is elevated, that he needs to take a break, that he should consider his lifestyle. The vocabulary is internally coherent. It is also clinically wrong. The condition the patient has is depression, and the management of depression is not the management of stress.
What the workup actually looks like
The diagnostic workup of suspected depression in the Nigerian professional cohort is not technically demanding. It is a structured history, a validated screening instrument, a focused physical, and a small bracket of biochemical tests to exclude the conditions that mimic the syndrome.
The structured history is the most important component, and it requires the clinician to ask the questions the patient will not raise on his own. The questions the patient is most reliably willing to answer truthfully when they are asked plainly are: across the last two years, has there been a clear loss of pleasure in the activities you used to enjoy on a Saturday? Has there been a clear change in the way you wake up at night? Have the people closest to you said, in some form, that you are not yourself? Are you drinking more than you were two years ago? Have you found yourself unable to feel emotional engagement at events that should have produced it — your children's milestones, a colleague's achievement, an outcome you had been working toward? Has there been a period in the last six months when the thought of not waking up tomorrow has been, in any form, present? The patient will, almost universally, give honest answers to these questions when they are asked. He will, almost universally, not raise any of these on his own.
The validated screening instrument — the Patient Health Questionnaire-9 (PHQ-9) is the cleanest — takes the patient three minutes to complete, scores in the consulting room in ten seconds, and stratifies the diagnostic possibility into ranges with clinical meaning. The instrument is free, public, validated in the African context across multiple cohorts, and almost never administered in Nigerian primary care for the asymptomatic-on-the-surface executive presenting with fatigue.
The focused physical examines the patient for the physical correlates of depression — the weight change, the psychomotor slowing, the affective flattening — and the conditions that mimic it. The biochemical panel checks the thyroid (subclinical hypothyroidism mimics depression closely), the vitamin B12, the vitamin D, the ferritin (severe iron deficiency mimics it as well), the morning cortisol (Cushing's and Addison's mimic it from opposite directions), and a basic metabolic panel. Each of the conditions that mimics depression is worth excluding, because the treatment of a thyroid-driven depressive picture is the treatment of the thyroid, not the antidepressant. The panel costs, in Lagos, in the order of forty-five thousand naira. It is almost never run as the first step in the workup of the tired fifty-five-year-old executive.
What treatment actually does
The treatment of depression in the cohort is, against the patient's prior expectations, considerably more effective and considerably less alarming than the patient anticipates entering the consultation. The honest description of what it involves is worth giving.
Pharmacological treatment, when indicated, is straightforward. The selective serotonin reuptake inhibitor — sertraline, escitalopram, or one of the related agents — at the standard starting dose for the adult, taken consistently for six to twelve months past the resolution of symptoms, produces, in the published cohort data, response rates somewhere in the order of fifty to sixty per cent at first agent and considerably higher with the second-line strategies if the first is partially effective. The side-effect profile of the modern SSRIs is, by the standards of medication the executive cohort tolerates routinely for other indications, mild. The pharmacology is not the obstacle. The willingness of the patient to begin it is.
Structured psychotherapy — cognitive-behavioural therapy delivered by a competent psychologist, weekly, across twelve to twenty sessions — is, on the comparative-effectiveness data, of roughly the same order of magnitude as pharmacological treatment alone for mild-to-moderate episodes, and is meaningfully additive in moderate-to-severe episodes. Lagos and Abuja have, increasingly, qualified practitioners in this discipline. The patient who refuses pharmacology can still be meaningfully helped by psychotherapy alone. The patient who accepts both is, on the evidence, in the best clinical position.
Behavioural and lifestyle interventions matter, but they matter as adjuncts rather than as substitutes for the primary treatment. Sleep restoration, structured exercise, alcohol reduction, and the structural offloading described in the chronic-stress companion piece all contribute. None of them, on the published data, treats a moderate-to-severe established depressive episode on their own. The patient who has been told by previous clinicians that he needs to "exercise more and sleep more" has been given correct adjunctive advice in the absence of the primary intervention that the case actually requires.
The honest practical observation is that the patient who begins treatment — pharmacological, psychotherapeutic, or both — begins to feel like himself again, in most cases, somewhere between four and eight weeks in, and that he describes the recovery, when he is asked, as the lifting of a condition he had not realised was a separate thing from his own personality. The standard sentence patients use, weeks into a successful treatment, is some version of I had forgotten what this was like.
The honest close
The piece is not an argument that every tired Nigerian professional is depressed. It is an argument that the prior probability of depression in the patient with the pattern at the top of this piece — two-plus years of fatigue, behavioural change visible to the family, early-morning awakening, increased alcohol, loss of pleasure in former pleasures, and the absence of a competing diagnosis on a proper workup — is much higher than the patient, the family, or the primary-care clinician currently treats it as. The screening costs nothing meaningful. The instrument is free. The blood panel is cheap. The treatment, when it is indicated, works in the majority of patients within weeks. The cost of not naming the diagnosis is, on the cohort data, a decade of unrecognised illness in the patient's most productive years.
The patient at the top of this piece, treated, is back at his desk fourteen weeks in, has resumed the Saturday golf, has had two consecutive Sundays his wife describes as the first in three years that he was present for, is no longer drinking the way he was, and is — for the first time since he first walked into his GP's office complaining of fatigue — managing without the inner conviction that he has become a slower, lesser version of himself that the years are going to keep stripping back. The diagnosis was not subtle. It was simply not made.
The Nigerian professional class is producing, in the practice's reading, a generation of men and women in their forties, fifties, and sixties who are clinically depressed and who have been told by everyone around them, for years, that they are not depressed — they are tired, they are stressed, they are Lagos. The vocabulary the country uses about the condition is the largest single obstacle to its treatment. The honest version of the conversation, including in the consulting room, begins by being willing to use the word.